Cheat Your Way Thin Research
(We Actually Back Up Our Claims)

research
How would you like to read 308 medical research papers full of terms like “acute lipolysis” and “neuroendocrine regulation”, and then try to make sense of all of them, and then try to figure out how to put it all into a program for optimal fat loss?

Not so much?

Fortunately, you’ll never have to do any that, because I’ve already done all the “hard work” for you, and I trust you can see just how much time, effort, and struggle I’m saving you (how much is that worth?) by giving you the "shorcut to success" I'm providing you with via the Cheat Your Way Thin system.

You see, over the course of a real 73 month period, I meticulously went through each and every one of the below studies while testing my findings over and over again with hundreds of clients in the real world.

The end result is this program—the complete, most up to date Cheat Your Way Thin system—based on strong science, proven to work in the real world (just take a look at some of the success stories).

If there’s anything I am, it’s a science geek, and while I don’t expect you to go read through any of the below papers (you certainly can if you’d like), I thought you might like to visually see just how much went into the creation of this program.

You really can use your favorite foods to lose weight faster than ever before, and I’ve got the science to back it up 308 times over.

 

Cheat Your Way Thin References

1.  Dubuc GR, Havel PJ et al. Changes of serum leptin and endocrine and metabolic parameters after 7 days of energy restriction in men and women. Metabolism. 1998 Apr;47(4):429-34.

2.  Klein S, et al. Leptin production during early starvation in lean and obese women. Am J Physiol Endocrinol Metab. 2000 Feb;278(2):E280-4.

3.  Dirlewanger M, et al. Effects of short-term carbohydrate or fat overfeeding on energy expenditure and plasma leptin concentrations in healthy female subjects. Int J Obes Relat Metab Disord. 2000 Nov;24(11):1413-8.

4.  Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000;62:413-37. Review.

5.  Bowles L, Kopelman P. Leptin: of mice and men? J Clin Pathol 2001 Jan;54(1):1-3

6.  Ahima RS, et al. Leptin regulation of neuroendocrine systems. Front Neuroendocrinolgy 2000 Jul;21(3):263-307.

7.  van Dijk G. The role of leptin in regulation of energy balance and adiposity. J Neuroendocrinol 2001 Oct;13(10):913-21.

8.  Rosenbaum M et. al. Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab (2002) 87:2391-2394.

9.  Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin North Am. 2002 Mar;31(1):173-89.

10.  Kennedy A et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab. 1997 Apr;82(4):1293-300.

10.  Havel PJ et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996 Dec;81(12):4406-13.

11.  Doucet E et al. Changes in energy expenditure and substrate oxidation resulting from weight loss in obese men and women: is there an important contribution of leptin? J Clin Endocrinol Metab. 2000 Apr;85(4):1550-6.

12.  Nicklas BJ et al. Gender differences in the response of plasma leptin concentrations to weight loss in obese older individuals.  Obes Res. 1997 Jan;5(1):62-8.

13.  Racette SB, Kohrt WM et al.  Response of serum leptin concentrations to 7 d of energy restriction in centrally obese African Americans with impaired or diabetic glucose tolerance.  Am J Clin Nutr. 1997 Jul;66(1):33-7.

14.  Havel PJ et al. High-fat meals reduce 24-h circulating leptin concentrations in women.  Diabetes. 1999 Feb;48(2):334-41.

15.  Borden G et al. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 1996 Sep;81(9):3419-23.

16.  Miyawaki T et al. Clinical implications of leptin and its potential humoral regulators in long-term low-calorie diet therapy for obese humans.  Eur J Clin Nutr. 2002 Jul;56(7):593-600.

17.  Carantoni M et al.  Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance?  J Clin Endocrinol Metab. 1999 Mar;84(3):869-72.

18.  Zimmet P. Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. BMJ. 1996 Oct 19;313(7063):965-9.

19.  Tuominen et al. Leptin and thermogenesis in humans. Acta Physiol Scand. 1997 May;160(1):83-7.

20.  Keim NL, Stern JS, Havel PJ. Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr. 1998 Oct;68(4):794-801.

21.  Haluzik M et al. The influence of short-term fasting on serum leptin levels, and selected hormonal and metabolic parameters in morbidly obese and lean females. Endocr Res. 2001 Feb-May;27(1-2):251-60.

22.  Mars M et al.  Leptin and insulin responses to a four-day energy-deficient diet in men with different weight history. Int J Obes Relat Metab Disord. 2003 May;27(5):574-81.

23.  Pratley RE et al. Plasma leptin responses to fasting in Pima Indians. Am J Physiol. 1997 Sep;273(3 Pt 1):E644-9.

24.  Okazaki T et al. Effects of mild aerobic exercise and a mild hypocaloric diet on plasma leptin in sedentary women. Clin Exp Pharmacol Physiol. 1999 May-Jun;26(5-6):415-20.

25.  Mars M et al. Fasting leptin and appetite responses induced by a 4-day 65%-energy-restricted diet. Int J Obes (Lond). 2006 Jan;30(1):122-8.

26.  Kolaczynski JW. Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes. 1996 Nov;45(11):1511-5.

27.  Kolaczynski JW. Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab. 1996 Nov;81(11):4162-5.

28.  Palesty JA. The goldilocks paradigm of starvation and refeeding. Nutr Clin Pract. 2006 Apr;21(2):147-54. Review.

29.  Havel PJ. Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proc Nutr Soc. 2000 Aug;59(3):359-71. Review.

30.  Reseland JE et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr. 2001 Feb;73(2):240-5.

40.  Romon M et al. Leptin response to carbohydrate or fat meal and association with subsequent satiety and energy intake. Am J Physiol. 1999 Nov;277(5 Pt 1):E855-61.

41.  van Aggel-Leijssen DP et al. Regulation of average 24h human plasma leptin level; the influence of exercise and physiological changes in energy balance. Int J Obes Relat Metab Disord. 1999 Feb;23(2):151-8.

42.  Hamann A, Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes. 1996;104(4):293-300. Review.

43.  Ahima RS et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996 Jul 18;382(6588):250-2.

44.  Meinders AE et al. Leptin. Neth J Med. 1996 Dec;49(6):247-52. Review.

45.  Girard J. Is leptin the link between obesity and insulin resistance? Diabetes Metab. 1997 Sep;23 Suppl 3:16-24. Review.

46.  Nedvidkova J. Leptin. Cesk Fysiol. 1997 Dec;46(4):182-8. Review.

47.  Spitzweg C, Joba W, Heufelder AE. Leptin—new knowledge on the pathogenesis of obesity. Med Klin (Munich). 1998 Aug 15;93(8):478-85. Review.

48.  Salidin R et al. Transient increase in obese gene expression after food intake or insulin administration. Nature. 1995 Oct 12;377(6549):527-9.

49.  Maffei M, Halaas J et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995 Nov;1(11):1155-61.

50.  McGarry JD. Appetite control: Does leptin lighten the problem of obesity? Curr Biol. 1995 Dec 1;5(12):1342-4. Review.

51.  Wolf G. Leptin: the weight-reducing plasma protein encoded by the obese gene. Nutr Rev. 1996 Mar;54(3):91-3. Review.

52.  Boden G et al.  Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab. 1996 Sep;81(9):3419-23.

53.  Levin BE, Routh VH. Role of the brain in energy balance and obesity. Am J Physiol. 1996 Sep;271(3 Pt 2):R491-500. Review.

54.  National Centre for Eating Disorders.  Psychology of Dieting.  1999. 

55.  Rowland  NE, Morien A, Li BH. The physiology and brain mechanisms of feeding. Nutrition. 1996 Sep;12(9):626-39. Review.

56.  Smith SR. The endocrinology of obesity. Endocrinol Metab Clin North Am. 1996 Dec;25(4):921-42. Review.

57.  Hwa JJ et al. Intracerebroventricular injection of leptin increases thermogenesis and mobilizes fat metabolism in ob/ob mice. Horm Metab Res. 1996 Dec;28(12):659-63.

58.  Wing RR et al. Relationship between weight loss maintenance and changes in serum leptin levels.  Horm Metab Res. 1996 Dec;28(12):698-703.

59.  Martinez JA, Fruhbek G. Regulation of energy balance and adiposity: a model with new approaches. Rev Esp Fisiol. 1996 Dec;52(4):255-8. Review.

60.  Schwartz MW, Seeley RJ. The new biology of body weight regulation. J Am Diet Assoc. 1997 Jan;97(1):54-8; quiz 59-60. Review.   

61.  Rohner-Jeanrenaud E, Jeanrenaud B. Central nervous system and body weight regulation. Ann Endocrinol (Paris). 1997;58(2):137-42. Review.

62.  Blum WF.  Leptin: the voice of the adipose tissue. Horm Res. 1997;48 Suppl 4:2-8. Review.

63.  Weigle DS et al. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab. 1997 Feb;82(2):561-5.

64.  Jenkins AB et al. Carbohydrate intake and short-term regulation of leptin in humans. Diabetologia. 1997 Mar;40(3):348-51.

65.  Arhen B et al. Regulation of circulating leptin in humans. Endocrine. 1997 Aug;7(1):1-8. Review.

66.  Hamalainen EK et al. Decrease of serum total and free testosterone during a low-fat high-fibre diet. J Steroid Biochem. Mar 1983; 18 (3): 369-370.

67.  Reed MJ et al. Dietary lipids: an additional regulator of plasma levels of sex hormone binding globulin. J. Clin. Endocrinol. Metab, 1987; 64: 1083-1085.

68.  Dorgan JF et al. Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study. Am J Clin Nutr. Dec 1996; 64 (6): 850-855.

69.  Volek JS et al. Testosterone and cortisol in relationship to dietary nutrients and resistance exercise. Journal of Applied Physiology, Jan 1997; 82 (1): 49-54.

70.  Hamalainen E et al. Diet and serum sex hormones in healthy men. J Steroid Biochem. 1984 Jan;20(1):459-64.

71.  Volek JS et al. Effects of a high-fat diet on postabsorptive and postprandial testosterone responses to a fat-rich meal. Metabolism. 2001 Nov;50(11):1351-5.

72.  Wang C et al. Low-fat high-fiber diet decreased serum and urine androgens in men. J Clin Endocrinol Metab. 2005 Jun;90(6):3550-9.

73.  Wolfe BM, Piche LA. Replacement of carbohydrate by protein in a conventional-fat diet reduces cholesterol and triglyceride concentrations in healthy normolipidemic subjects. Clin Invest Med. 1999 Aug;22(4):140-8.

74.  Nelson GJ, Schmidt PC, Kelley DS.  Low-fat diets do not lower plasma cholesterol levels in healthy men compared to high-fat diets with similar fatty acid composition at constant caloric intake. Lipids. 1995 Nov;30(11):969-76.

75.  Berglund L et al. HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects. Am J Clin Nutr. 1999 Dec;70(6):992-1000.

76.  Sanders TA et al. Influence of n-6 versus n-3 polyunsaturated fatty acids in diets low in saturated fatty acids on plasma lipoproteins and hemostatic factors. Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3449-60.

77.  Smith RD et al. Long-term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjects. Br J Nutr. 2003 Sep;90(3):597-606.

78.  Knopp RH et al. One-year effects of increasingly fat-restricted, carbohydrate-enriched diets on lipoprotein levels in free-living subjects. Proc Soc Exp Biol Med. 2000 Dec;225(3):191-9.

79.  Matte, R. Position of the American Dietetic Association: fat replacers. J Am Diet Assoc 98: 463-468, 1998.

80.  Keys, A., et al. Serum cholesterol response to changes in the diet Metab 14: 776-787, 1965.

81.  Kris-Etherton, P., et al. Effects of dietary stearic acid on plasma lipids and thrombosis. Nutr Today 28(3): 30-38, 1993.

82.  Hegsted, D., et al. Quantitative effects of dietary fat on serum cholesterol in man, Am J Clin Nutr 17: 281-295, 1965.

83.  Ahrens, E., et al. The influence of dietary fats on serum lipid levels in man. Lancet 1: 943-953, 1957.

84.  Popkin, B., et al. Where's the fat? Trends in US diets 1965-1996. Preventive Medicine, 32(3): 245-254, 2001.
Raper, N., et al. Nutrient content of the US food supply, 1909-1988. USDA Home Econ Res Rep. 50, 1992.

85.  McCarger, L., et al. Dietary carbohydrate-to-fat ratio: influence on whole-body nitrogen retention, substrate utilization and hormone response in healthy male subjects. Am J Clin Nutr 49:1169-1178, 1988.

85.  Davis BC, Kris-Etherton PM. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am J Clin Nutr. 2003 Sep;78(3 Suppl):640S-646S.

86.  Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr. 2002 Oct;88(4):411-20.

87.  Harper CR, Jacobson TA. The fats of life: the role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med. 2001 Oct 8;161(18):2185-92.

88.  Calder PC. n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab. 1997;41(4):203-34.

89.  Yamada T et al. Atherosclerosis and omega-3 fatty acids in the populations of a fishing village and a farming village in Japan. Atherosclerosis. 2000 Dec;153(2):469-81.

90.  Durrington PN et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart. 2001 May;85(5):544-8.

91.  Nordoy A, Marchioli R, Arnesen H, Videbaek J. n-3 polyunsaturated fatty acids and cardiovascular diseases. Lipids. 2001;36 Suppl:S127-9.

92.  Engler MM et al. Effects of docosahexaenoic acid on vascular pathology and reactivity in hypertension. Exp Biol Med (Maywood). 2003 Mar;228(3):299-307.

93.  Passfall J et al. Different effects of eicosapentaenoic acid and olive oil on blood pressure, intracellular free platelet calcium, and plasma lipids in patients with essential hypertension. Clin Investig. 1993 Aug;71(8):628-33.

94.  Bhatnagar D, Durrington PN.Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. Int J Clin Pract. 2003 May;57(4):305-14

95.  Holm T et al. Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients. Eur Heart J. 2001 Mar;22(5):428-36.

96.  Curtis CL et al. Effects of n-3 fatty acids on cartilage metabolism. Proc Nutr Soc. 2002 Aug;61(3):381-9.

97.  Curtis CL et al. Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. Arthritis Rheum. 2002 Jun;46(6):1544-53.

98.  Cho SH et al. Clinical efficacy and safety of Lyprinol, a patented extract from New Zealand green-lipped mussel (Perna Canaliculus) in patients with osteoarthritis of the hip and knee: a multicenter 2-month clinical trial. Allerg Immunol (Paris). 2003 Jun;35(6):212-6.

99.  Kremer JM. n-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr. 2000 Jan;71(1 Suppl):349S-51S

100.  Tidow-Kebritchi S et al. Effects of diets containing fish oil and vitamin E on rheumatoid arthritis. Nutr Rev. 2001 Oct;59(10):335-8.

101.  Rennie KL, Hughes J, Lang R, Jebb SA. Nutritional management of rheumatoid arthritis: a review of the evidence. J Hum Nutr Diet. 2003 Apr;16(2):97-109.

102.  Nagakura T et al. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J. 2000 Nov;16(5):861-5.

103.  Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003 Nov 15;168(10):1181-9. Epub 2003 Aug 06.

104.  De Vizia B et al. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J Parenter Enteral Nutr. 2003 Jan-Feb;27(1):52-7.

105.  Shahar E et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. Atherosclerosis Risk in Communities Study Investigators. N Engl J Med. 1994 Jul 28;331(4):228-33.

106.  Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev. 2001;23(2):268-87.

107.  Tomer A et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids. Thromb Haemost. 2001 Jun;85(6):966-74.

108.  Glew RH et al. The fatty acid composition of the serum phospholipids of children with sickle cell disease in Nigeria. Prostaglandins Leukot Essent Fatty Acids. 2002 Oct;67(4):217-22.

109.  Barbosa DS, Cecchini R, El Kadri MZ, Rodriguez MA, Burini RC, Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition. 2003 Oct;19(10):837-42.

110.  Cellini M, Caramazza N, Mangiafico P, Possati GL, Caramazza R. Fatty acid use in glaucomatous optic neuropathy treatment. Acta Ophthalmol Scand Suppl. 1998; (227): 41-2.

111.  Cunnane SC, Ho SY, Dore-Duffy P, Ells KR, Horrobin DF. Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. Am J Clin Nutr. 1989 Oct;50(4):801-6.

112.  Gallai V et al. Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol. 1995 Feb;56(2):143-53.

113.  Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol. 2003 Mar;101(3):469-79.

114.  Stene LC, Joner G; Norwegian Childhood Diabetes Study Group. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr. 2003 Dec;78(6):1128-34.

115. Malcolm CA, McCulloch DL, Montgomery C, Shepherd A, Weaver LT. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed. 2003 Sep;88(5):F383-90.

116.  Uauy R, Hoffman DR, Mena P, Llanos A, Birch EE. Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J Pediatr. 2003 Oct;143(4 Suppl):S17-25.

117.  Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. Essential fatty acids in visual and brain development. Lipids. 2001 Sep;36(9):885-95.

118.  Dunstan JA et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: A randomized, controlled trial. J Allergy Clin Immunol. 2003 Dec;112(6):1178-84.

119.  Williams MA, Zingheim RW, King IB, Zebelman AM. Omega-3 fatty acids in maternal erythrocytes and risk of preeclampsia. Epidemiology. 1995 May; 6(3): 232-7.

120.  Mayser P et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol. 1998 Apr;38(4):539-47.

121.  Grimminger F et al. A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile. Clin Investig. 1993 Aug;71(8):634-43.

122.  Rhodes LE, White SI. Dietary fish oil as a photoprotective agent in hydroa vacciniforme. Br J Dermatol. 1998 Jan;138(1):173-8.

123.  Jain S, Gaiha M, Bhattacharjee J, Anuradha S. Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress—a prospective preliminary study. J Assoc Physicians India. 2002 Aug;50:1028-33.

124.  Fernandez-Real JM, Broch M, Vendrell J, Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care. 2003 May;26(5):1362-8.

125.  Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willett WC. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001 Jun;73(6):1019-26.

126.  Chicco, A., D'Alessandro, M. E., Karabatas, L., Gutman, R., and Lombardo, Y. B. Effect of moderate levels of dietary fish oil on insulin secretion and sensitivity, and pancreas insulin content in normal rats. Ann Nutr Metab 40(2), 61-70. 1996.

127.  Mori, TA et al. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70(5), 817-25. 1999.

128.  Rivellese AA, Maffettone A, Iovine C, Di Marino L, Annuzzi G, Mancini M, Riccardi G. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Diabetes Care. 1996 Nov;19(11):1207-13.

129.  Woodman RJ et al. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr. 2002 Nov;76(5):1007-15.

130.  Berardi, J. The Real World (of Physique Research), Part 3. Testosterone Magazine. 8 Aug 2003. http://www.t-mag.com/nation_articles/273real.jsp.

131.  Cha, M. C. and Jones, P. J. Dietary fat type and energy restriction interactively influence plasma leptin concentration in rats. J Lipid Res 39(8), 1655-60. 1998.

132.  Peyron-Caso E, Taverna M, Guerre-Millo M, Veronese A, Pacher N, Slama G, Rizkalla SW. Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulin-resistant rats. J Nutr. 2002 Aug;132(8):2235-40.

133.  Su W, Jones PJ. Dietary fatty acid composition influences energy accretion in rats. J Nutr. 1993 Dec;123(12):2109-14.

134.  Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY. Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999 Mar 22;85(3):275-91.

135.  Hibbeln JR, Salem N Jr. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995 Jul;62(1):1-9.

136.  Peet M. Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results. Prostaglandins Leukot Essent Fatty Acids. 2003 Dec;69(6):477-85.

137.  Su KP, Huang SY, Chiu CC, Shen WW. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol. 2003 Aug;13(4):267-71.

138.  Zanarini MC, Frankenburg FR. omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study. Am J Psychiatry. 2003 Jan;160(1):167-9.

139.  Richardson AJ, Puri BK. The potential role of fatty acids in attention-deficit/hyperactivity disorder.Prostaglandins Leukot Essent Fatty Acids. 2000 Jul-Aug;63(1-2):79-87. Review

140.  Kidd PM. Attention deficit/hyperactivity disorder (ADHD) in children: rationale for its integrative management. Altern Med Rev. 2000 Oct;5(5):402-28. Review

141.  Delarue J, Matzinger O, Binnert C, Schneiter P, Chiolero R, Tappy L. Fish oil prevents the adrenal activation elicited by mental stress in healthy men. Diabetes Metab. 2003 Jun;29(3):289-95.

142.  Maes M, Christophe A, Bosmans E, Lin A, Neels H. In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol Psychiatry. 2000 May 15;47(10):910-20.

143.  Harel Z, Gascon G, Riggs S, Vaz R, Brown W, Exil G. Supplementation with omega-3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health. 2002 Aug;31(2):154-61.

144.  Rabinovitz S, Mostofsky DI, Yehuda S. Anticonvulsant efficiency, behavioral performance and cortisol levels: a comparison of carbamazepine (CBZ) and a fatty acid compound (SR-3). Psychoneuroendocrinology. 2004 Feb;29(2):113-24.

145.  Tamizi far B, Tamizi B. Treatment of chronic fatigue syndrome by dietary supplementation with omega-3 fatty acids—a good idea? Med Hypotheses. 2002 Mar;58(3):249-50.

146.  Ernst E. Complementary and alternative medicine in rheumatology. Baillieres Best Pract Res Clin Rheumatol. 2000 Dec;14(4):731-49.

147.  Hayashi H, Tanaka Y, Hibino H, Umeda Y, Kawamitsu H, Fujimoto H, Amakawa T. Beneficial effect of salmon roe phosphatidylcholine in chronic liver disease. Curr Med Res Opin. 1999;15(3):177-84.

148.  DiGiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study. Am J Med. 1989 Feb;86(2):158-64.

149.  Ioannou Y, Isenberg DA. Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge. Postgrad Med J. 2002 Oct;78(924):599-606.

150.  Das UN. Beneficial effect of eicosapentaenoic and docosahexaenoic acids in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leukot Essent Fatty Acids. 1994 Sep;51(3):207-13.

151.  Mohan IK, Das UN. Oxidant stress, anti-oxidants and essential fatty acids in systemic lupus erythematosus. Prostaglandins Leukot Essent Fatty Acids. 1997 Mar;56(3):193-8.

152.  Ilowite NT, Copperman N, Leicht T, Kwong T, Jacobson MS. Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus. J Rheumatol. 1995 Jul;22(7):1347-51.

153.  Albertazzi P, Coupland K. Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? Maturitas. 2002 May 20;42(1):13-22.

154.  Donadio JV. n-3 Fatty acids and their role in nephrologic practice. Curr Opin Nephrol Hypertens. 2001 Sep;10(5):639-42.

155.  Vergili-Nelsen JM. Benefits of fish oil supplementation for hemodialysis patients. J Am Diet Assoc. 2003 Sep;103(9):1174-7.

156.  Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991 Sep;54(3):438-63.

157.  Terry P, Lichtenstein P, Feychting M, Ahlbom A, Wolk A. Fatty fish consumption and risk of prostate cancer. Lancet. 2001 Jun 2;357(9270):1764-6.

158.  Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, Willett WC, Giovannucci E. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):64-7.

159.  Collett ED, Davidson LA, Fan YY, Lupton JR, Chapkin RS. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol. 2001 May;280(5):C1066-75.

160.  Gago-Dominguez M, Yuan JM, Sun CL, Lee HP, Yu MC. Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study. Br J Cancer. 2003 Nov 3;89(9):1686-92.

161.  Rhodes LE et al. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers. Carcinogenesis. 2003 May;24(5):919-25.

162. Belluzzi A, Brignola C, Campieri M, Pera A, Boschi S, Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996 Jun 13; 334(24): 1557-60.

163. Howard BV, et al. Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. Journal of the American Medical Association, Feb 8, 2006; 295: 655-666.

164. Prentice RL, et al. Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. Journal of the American Medical Association, Feb 8, 2006; 295: 629-642.

165. Beresford SAA, et al. Low-Fat Dietary Pattern and Risk of Colorectal Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial. Journal of the American Medical Association, Feb 8, 2006; 295: 643-654.

166. Mozaffarian D, et al. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. American Journal of Clinical Nutrition, 2004; 80: 1175-1184.

167.  Dirlewanger M, et al. Effects of short-term carbohydrate or fat overfeeding on energy expenditure and plasma leptin concentrations in healthy female subjects. Int J Obes Relat Metab Disord. 2000 Nov;24(11):1413-8.

168.  Havel PJ et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996 Dec;81(12):4406-13.

169.  Carantoni M et al.  Can changes in plasma insulin concentration explain the variability in leptin response to weight loss in obese women with normal glucose tolerance?  J Clin Endocrinol Metab. 1999 Mar;84(3):869-72.

170.  Mars M et al.  Leptin and insulin responses to a four-day energy-deficient diet in men with different weight history. Int J Obes Relat Metab Disord. 2003 May;27(5):574-81.

171.  Romon M et al. Leptin response to carbohydrate or fat meal and association with subsequent satiety and energy intake. Am J Physiol. 1999 Nov;277(5 Pt 1):E855-61.

172.  Jenkins AB et al. Carbohydrate intake and short-term regulation of leptin in humans. Diabetologia. 1997 Mar;40(3):348-51.

173.  Meksawan K et al. Effect of low and high fat diets on nutrient intakes and selected cardiovascular risk factors in sedentary men and women. J Am Coll Nutr. 2004 Apr;23(2):131-40.

174.  Garg A et al. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1988 Sep 29;319(13):829-34.

175.  Kobayashi N et al. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res. 2006 Aug 1;12(15):4662-70.

176.  Wijendran V, Hayes KC. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr. 2004;24:597-615. Review.

177.  Wahrburg U. What are the health effects of fat? Eur J Nutr. 2004 Mar;43 Suppl 1:I/6-11. Review.

178.  Kris-Etherton PM. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr. 2000 Jan;71(1 Suppl):179S-88S. Review.

179.  Ghafoorunissa. Requirements of dietary fats to meet nutritional needs & prevent the risk of atherosclerosis—an Indian perspective. Indian J Med Res. 1998 Nov;108:191-202. Review.

180.  Noakes M et al. Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk. Nutr Metab (Lond). 2006 Jan 11;3:7.

181.  Rivellese AA et al. Long term metabolic effects of two dietary methods of treating hyperlipidaemia. BMJ. 1994 Jan 22;308(6923):227-31.

182.  Lean ME et al. Weight loss with high and low carbohydrate 1200 kcal diets in free living women. Eur J Clin Nutr. 1997 Apr;51(4):243-8.

183.  Sargrad KR et al. Effect of high protein vs high carbohydrate intake on insulin sensitivity, body weight, hemoglobin A1c, and blood pressure in patients with type 2 diabetes mellitus. J Am Diet Assoc. 2005 Apr;105(4):573-80.

184.  Newbold, HL. Reducing the serum cholesterol level with a diet high in animal fat. South Med J. Jan;81(1):61-3, 1988.

185.  Aro, A., et al. Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein (a), and lipid transfer proteins in healthy subjects. Am. J. Clin. Nutri., 65: 1419, 1997.

186.  ASCN/AIN Task Force on Trans Fatty Acids: Position paper on trans fatty acids. Am. J. Clin. Nutri., 63:663, 1996.

187.  Hunger, JE, and Applewhite, T.H. Reassessment of trans fatty acid availability in the U.S. Am. J. Clin. Nutri., 54:363, 1991.

188.  Troisi, R., et al. Trans-fatty acid intake in relation to serum lipid concentrations in adult men. Am. J. clin. Nutri., 56:1019, 1992.

189.  Collier, G. and O'Dea, K. The effect of coingestion of fat on the glucose, insulin and gastric inhibitory peptide responses to carbohydrate and protein. Am J Clin Nutr 37: 941-944.

190.  Dirlewanger M, et al. Effects of short-term carbohydrate or fat overfeeding on energy expenditure and plasma leptin concentrations in healthy female subjects. Int J Obes Relat Metab Disord. 2000 Nov;24(11):1413-8.

191.  Havel PJ et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996 Dec;81(12):4406-13.

192.  Romon M et al. Leptin response to carbohydrate or fat meal and association with subsequent satiety and energy intake. Am J Physiol. 1999 Nov;277(5 Pt 1):E855-61.

193.  Jenkins AB et al. Carbohydrate intake and short-term regulation of leptin in humans. Diabetologia. 1997 Mar;40(3):348-51.

194.  Atkins and other low-carbohydrate diets: hoax or an effective tool for weight loss? Lancet. 2004 Sep 4-10;364(9437):897-9. Review.

195.  Louis-Sylvestre J et al. Highlighting the positive impact of increasing feeding frequency on metabolism and weight management. Forum Nutr. 2003;56:126-8. Review.

196.  Kirt TR. Role of dietary carbohydrate and frequent eating in body-weight control. Proc Nutr Soc. 2000 Aug;59(3):349-58. Review. 

197.  Farshchi HR et al. Decreased thermic effect of food after an irregular compared with a regular meal pattern in healthy lean women. Int J Obes Relat Metab Disord. 2004 May;28(5):653-60.

198.  Farshchi HR et al. Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. Am J Clin Nutr. 2005 Jan;81(1):16-24.

199.  Cho S et al. The effect of breakfast type on total daily energy intake and body mass index: results from the Third National Health and Nutrition Examination Survey (NHANES III). J Am Coll Nutr. 2003 Aug;22(4):296-302.

200.  Farshchi HR et al. Deleterious effects of omitting breakfast on insulin sensitivity and fasting lipid profiles in healthy lean women. Am J Clin Nutr. 2005 Feb;81(2):388-96.

201.  Belko AZ et al. Effect of energy and protein intake and exercise intensity on the thermic effect of food. Am J Clin Nutr. 1986 Jun;43(6):863-9.

202.  Kinabo JL, Durnin JV.  Thermic effect of food in man: effect of meal composition, and energy content. Br J Nutr. 1990 Jul;64(1):37-44.

203.  Schutz Y et al. Postprandial thermogenesis at rest and during exercise in elderly men ingesting two levels of protein. J Am Coll Nutr. 1987 Dec;6(6):497-506.

204.  Nair KS et al. Thermic response to isoenergetic protein, carbohydrate or fat meals in lean and obese subjects. Clin Sci (Lond). 1983 Sep;65(3):307-12.

205.  Karst H et al. Diet-induced thermogenesis in man: thermic effects of single proteins, carbohydrates and fats depending on their energy amount. Ann Nutr Metab. 1984;28(4):245-52.

206.  U.S. National Library of Medicine and National Institutes of Health. Protein in diet. Medline Plus Medical Encyclopedia. 2003.

207.  Westerterp-Plantenga MS. High protein intake sustains weight maintenance after body weight loss in humans. Int J Obes Relat Metab Disord. 2004 Jan;28(1):57-64.

209.  Calissendorff J et al. Is decreased leptin secretion after alcohol ingestion catecholamine-mediated? Alcohol Alcohol. 2004 Jul-Aug;39(4):281-6.

210.  Rojdmark S et al. Alcohol ingestion decreases both diurnal and nocturnal secretion of leptin in healthy individuals. Clin Endocrinol (Oxf). 2001 Nov;55(5):639-47.

211.  Dammann G et al. No significant effect of acute moderate alcohol intake on leptin levels in healthy male volunteers. Addict Biol. 2005 Dec;10(4):357-64.

212.  Reseland JE et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr. 2001 Feb;73(2):240-5
Chu NF et al. Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men. Int J Obes Relat Metab Disord. 2001 Jan;25(1):106-14.

213.  Koutsari C et al. Plasma leptin is influenced by diet composition and exercise. Int J Obes Relat Metab Disord. 2003 Aug;27(8):901-6.

214.  Hamann A, Matthaei S. Regulation of energy balance by leptin. Exp Clin Endocrinol Diabetes. 1996;104(4):293-300. Review.

215.  Scholz GH et al. Dissociation of serum leptin concentration and body fat content during long term dietary intervention in obese individuals. Horm Metab Res. 1996 Dec;28(12):718-23.

216.  Ur E, Grossman A, Despres JP. Obesity results as a consequence of glucocorticoid induced leptin resistance. Horm Metab Res. 1996 Dec;28(12):744-7. Review.

217.  Diamond FB Jr et al. Demonstration of a leptin binding factor in human serum. Biochem Biophys Res Commun. 1997 Apr 28;233(3):818-22.

218.  Haffner SM et al. Leptin concentrations and insulin sensitivity in normoglycemic men. Int J Obes Relat Metab Disord. 1997 May;21(5):393-9.

219.  Hernandez Morin N, Perlemuter L. Leptin: a genetic solution to obesity? Presse Med. 1997 May 17;26(16):770-3.

220.  Haffner SM et al. Leptin concentrations, sex hormones, and cortisol in nondiabetic men. J Clin Endocrinol Metab. 1997 Jun;82(6):1807-9.

221.  Halaas JL et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8878-83.

222.  Fine JB, Fine RM. Leptin levels in obesity. Int J Dermatol. 1997 Oct;36(10):727-8.

223.  Sinha MK, Caro JF. Clinical aspects of leptin. Vitam Horm. 1998;54:1-30. Review.

224.  Prolo P, Wong ML, Licinio J. Leptin. Int J Biochem Cell Biol. 1998 Dec;30(12):1285-90. Review.

225.  Barinaga M. "Obese" protein slims mice. Science. 1995 Jul 28;269(5223):475-6.

226.  Halaas JL et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995 Jul 28;269(5223):543-6.

227.  Lonnqvist F et al. Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med. 1995 Sep;1(9):950-3.

228.  Increased obese mRNA expression in omental fat cells from massively obese humans. Nat Med. 1995 Sep;1(9):953-6.

229.  Maffei M, Halaas J et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995 Nov;1(11):1155-61.

230.  Considine RV, Caro JF. Leptin: genes, concepts and clinical perspective. Horm Res. 1996;46(6):249-56. Review.

231.  Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 1996 Jul;45(7):988-91.

232.  Smith SR. The endocrinology of obesity. Endocrinol Metab Clin North Am. 1996 Dec;25(4):921-42. Review.

233.  Carlsson B et al. Obese (ob) gene defects are rare in human obesity. Obes Res. 1997 Jan;5(1):30-5.

234.  Rohner-Jeanrenaud E, Jeanrenaud B. Central nervous system and body weight regulation. Ann Endocrinol (Paris). 1997;58(2):137-42. Review.

235.  Jenkins AB et al. Carbohydrate intake and short-term regulation of leptin in humans. Diabetologia. 1997 Mar;40(3):348-51.

236.  Echwald SM et al. Identification of two novel missense mutations in the human OB gene. Int J Obes Relat Metab Disord. 1997 Apr;21(4):321-6.

237.  Atanassova N et al. Comparative Effects of Neonatal Exposure of Male Rats to Potent and Weak (Environmental) Estrogens on Spermatogenesis at Puberty and the Relationship to Adult Testis Size and Fertility: Evidence for Stimulatory Effects of Low Estrogen Levels. Endocrinology.  2000 Vol. 141, No. 10.

238.  Chorazy PA et al. Persistent hypothyroidism in an infant receiving a soy formula: case report and review of the literature. Pediatrics.  1995 Jul: 96 (1 Pt 1): 148-50.

239.  Irvine CHG et al. Phytoestrogens in soy-based infant foods: concentrations, daily intake, and possible biological effects. Proc Soc Exp Biol Med. 1998 Mar; 217 (3): 247-53.

240.  Lohrke B et al. Activation of skeletal muscle protein breakdown following consumption of soybean protein in pigs. Br J Nutr. 2001 Apr; 85 (4): 447-57.

241.  Nagata C et al. Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer. 2000; 36 (1): 14-8.

242.  Newbold RR et al. Uterine Adenocarcinoma in Mice Treated Neonatally with Genistein. Cancer Research. 2001; 61, 4325-4328.

243.  Pollard M et al. Prevention of spontaneous prostate-related cancer in Lobund-Wistar rats by soy protein isolate/isoflavone diet. Prostate. 2000 Oct 1; 45 (2): 101-5.

244.  Strauss L et al. Genistein exerts estrogen-like effects in male mouse reproductive tract. Mol Cell Endocrinol. 1998 Sep 25; 144 (1-2): 83-93.

245.  Weber KS et al. Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats. J Endocrinol. 2001 Sep; 170 (3): 591-9.

246.  Strauss et al. Genistein exerts estrogen-like effects in male mouse reproductive tract, Mol Cell Endocrinol. 1998 Sep 25;144(1-2);83-93.

247.  Casanova M et al. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and diadzein with rat estrogen receptors alpha and beta in vitro. Toxicol Sci. 1999 Oct;51(2):236-44

248.  Kumi-Diaka J et al. Cytotoxic potential of the phytochemical genistein isoflavone and certain environmental chemical compounds on testicular cells. Biol Cell. 1999 Sep;91 (7): 515-23.

249.  Anderson et al. Effect of various genotoxins and reproductive toxins in human lymphocytes and sperm in Comet assay. Teratog Carcinog Mutagen. 1997;17(1);29-43.

250.  Zhong et al. Effects of dietary supplement of soy protein isolate and low fat diet on prostate cancer. FASEB J 2000;14(4):a531.11.

251.  Nagata C et al. Inverse association of soy product intake with serum androgen and estrogen concentrations in Japanese men. Nutr Cancer 2000;36(1):14-8.

252.  Habito RC et al. Effects of replacing meat with soyabean in the diet on sex hormone concentrations in healthy adult males. Br J Nutr 2000 Oct;84(4):557-63.

253.  Klein M et al. Energy metabolism and thyroid hormone levels of growing rats in response to different dietary proteins - soy or casein. Arch Tierernahr 2000;53(2):99-125.

254.  Flynn KM et al. Effects of genistein exposure on sexually dimorphic behaviors in rats. Toxicol Sci 2000 Jun;55(2):311-9.

255.  Atanassova N et al. Comparative effects of neonatal exposure of male rats to potent and weak (environmental) estrogens on spermatogenesis at puberty and the relationship to adult testis size and fertility: evidence for stimulatory effects of low estrogen levels. Endocrinology 2000 Oct;141(10):3898-907.

256.  Whitten PL et al. Phytoestrogen influences on the development of behavior and gonadotropin function. Proc Soc Exp Biol Med 1995 Jan;208(1):82-6

257.  Kumi-Diaka J, et al. Cytotoxic potential of the phytochemical genistein isoflavone (4',5',7-trihydroxyisoflavone) and certain environmental chemical compounds on testicular cells. Biol Cell 1999 Sep;91(7):515-23

258.  Ashton E, Ball M. Effects of soy as tofu vs meat on lipoprotein concentrations. Eur J Clin Nutr 2000 Jan;54(1):14-9

259.  Madani S, et al. Dietary protein level and origin (casein and highly purified soybean protein) affect hepatic storage, plasma lipid transport, and antioxidative defense status in the rat. Nutrition 2000 May;16(5):368-75.

260.  Cline JM. Effects of dietary isoflavone aglycones on the reproductive tract of male and female mice. Toxicol Pathol. 2004 Jan-Feb;32(1):91-9.

261.  Dillingham BL et al. Soy protein isolates of varying isoflavone content exert minor effects on serum reproductive hormones in healthy young men. J Nutr. 2005 Mar;135(3):584-91.

262.  Sacks FM et al: American Heart Association Nutrition Committee. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation. 2006 Feb 21;113(7):1034-44. Epub 2006 Jan 17.

263.  Sirtori CR et al. Phytoestrogens: end of a tale? Ann Med. 2005;37(6):423-38. Review.

264.  American Dietetic Association.  Position of the American Dietetic Association: use of nutritive and nonnutritive sweeteners.  J Am Diet Assoc.  2004 Feb;104(2):255-75.

265.  Bertorelli AM, Czarnowski-Hill JV.  Review of present and future use of nonnutritive sweeteners. Diabetes Educ. 1990 Sep-Oct;16(5):415-22. Review.

266.  Kanders BS et al.  An evaluation of the effect of aspartame on weight loss.  Appetite.  1988; 11 Suppl 1:73-84.

267.  Blackburn GL et al.  The effect of aspartame as part of a multidisciplinary weight-control program on short- and long-term control of body weight.  Am J Clin Nutr. 1997 Feb;65(2):409-18.

268.  Aspartame. Review of safety issues. Council on Scientific Affairs.  JAMA. 1985 Jul 19;254(3):400-2.

269.  Blackburn GL.  Sweeteners and weight control. World Rev Nutr Diet. 1999;85:77-87. Review.

270.  Rolls BJ. Effects of intense sweeteners on hunger, food intake, and body weight: a review.  Am J Clin Nutr. 1991 Apr;53(4):872-8.

271.  Butchko HH et al.  Aspartame: review of safety.  Regul Toxicol Pharmacol. 2002 Apr;35(2 Pt 2):S1-93.

272.  Dirlewanger M, et al. Effects of short-term carbohydrate or fat overfeeding on energy expenditure and plasma leptin concentrations in healthy female subjects. Int J Obes Relat Metab Disord. 2000 Nov;24(11):1413-8.

273.  Havel PJ et al. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996 Dec;81(12):4406-13.

274.  Romon M et al. Leptin response to carbohydrate or fat meal and association with subsequent satiety and energy intake. Am J Physiol. 1999 Nov;277(5 Pt 1):E855-61.

275.  Jenkins AB et al. Carbohydrate intake and short-term regulation of leptin in humans. Diabetologia. 1997 Mar;40(3):348-51.

276.  Rodas G et al. A short training programme for the rapid improvement of both aerobic and anaerobic metabolism. Eur J Appl Physiol. 2000 Aug;82(5-6):480-6.

277.  Tremblay A et al. Impact on exercise intensity on body fatness and skeletal muscle metabolism. Metabolism 1994 Jul;43(7):814-8.

278.  Tabata I et al. Metabolic profile of high intensity intermittent exercises. Med Sci Sports Exerc 1997 Mar;29(3):390-5.

279.  Tabata I et al. Effects of moderate-intensity endurance and high-intensity intermittent training on anaerobic capacity and VO2max. Med Sci Sports Exerc 1996 Oct;28(10):1327-30.

280.  Gullstrand L. Physiological responses to short-duration high-intensity intermittent rowing. Can J Appl Physiol 1996 Jun;21(3):197-208.

281.  Bahr R et al. Effect of Intensity on Excess Post exercise O2 Consumption. Metabolism 40.8 (1991) : 836-841.

282.  Smith J et al. The Effects of Intensity of Exercise and Excess Post-Exercise Oxygen Consumption and Energy Expenditure in Moderately Trained Men and Women. European Journal of Applied Physiology 67 (1993) : 420-425.

283.  Lee YS et al. The effects of various intensities and durations of exercise with and without glucose in milk ingestion on postexercise oxygen consumption. J Sports Med Phys Fitness. 1999 Dec;39(4):341-7.

284.  Diboll DC et al. Cardiovascular and metabolic responses during 30 minutes of treadmill exercise shortly after consuming a small, high-carbohydrate meal. Int J Sports Med. 1999 Aug;20(6):384-9.

285.  Bahr R et al. Effect of feeding and fasting on excess postexercise oxygen consumption. Appl Physiol. 1991 Dec;71(6):2088-93.

286.  Bergman BC et al. Respiratory gas-exchange ratios during graded exercise in fed and fasted trained and untrained men. J Appl Physiol. 1999 Feb;86(2):479-87.

287.  Schabort EJ et al. The effect of a preexercise meal on time to fatigue during prolonged cycling exercise. Med Sci Sports Exerc. 1999 Mar;31(3):464-71.

288.  Borsheim E, Bahr R. Effect of exercise intensity, duration and mode on post-exercise oxygen consumption. Sports Med. 2003;33(14):1037-60. Review.

289.  Tomlin DL, Wenger HA. The relationship between aerobic fitness and recovery from high intensity intermittent exercise. Sports Med. 2001;31(1):1-11. Review.

290.  Yoshioka M et al. Impact of high-intensity exercise on energy expenditure, lipid oxidation and body fatness. Int J Obes Relat Metab Disord. 2001 Mar;25(3):332-9.

291.  Tremblay A et al. Effect of intensity of physical activity on body fatness and fat distribution. Am J Clin Nutr. 1990 Feb;51(2):153-7.

292.  Tremblay A, Doucet E. Influence of intense physical activity on energy balance and body fatness. Proc Nutr Soc. 1999 Feb;58(1):99-105. Review.

293.  Gutin B et al. Effects of exercise intensity on cardiovascular fitness, total body composition, and visceral adiposity of obese adolescents. Am J Clin Nutr. 2002 May;75(5):818-26.

294.  Phelain JF et al. Postexercise energy expenditure and substrate oxidation in young women resulting from exercise bouts of different intensity. J Am Coll Nutr. 1997 Apr;16(2):140-6.

295.  Reseland JE et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr. 2001 Feb;73(2):240-5.

296.  Chu NF et al. Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men. Int J Obes Relat Metab Disord. 2001 Jan;25(1):106-14.

297.  Koutsari C et al. Plasma leptin is influenced by diet composition and exercise. Int J Obes Relat Metab Disord. 2003 Aug;27(8):901-6.

298.  Kondo T et al. Effect of exercise on circulating adipokine levels in obese young women. Endocr J. 2006 Apr;53(2):189-95.

299.  Unal M et al. Investigation of serum leptin levels and VO2max value in trained young male athletes and healthy males. Acta Physiol Hung. 2005;92(2):173-9.

300.  Ishigaki T et al. Plasma leptin levels of elite endurance runners after heavy endurance training. J Physiol Anthropol Appl Human Sci. 2005 Nov;24(6):573-8.

301.  Haluzik M et al. Effect of aerobic training in top athletes on serum leptin: comparison with healthy non-athletes. Vnitr Lek. 1999 Jan;45(1):51-4. Czech.

302.  Steinberg GR et al. Endurance training partially reverses dietary-induced leptin resistance in rodent skeletal muscle. Am J Physiol Endocrinol Metab. 2004 Jan;286(1):E57-63.

303.  Frank LL et al. Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res. 2005 Mar;13(3):615-25.

304.  Lakka TA et al. Leptin and leptin receptor gene polymorphisms and changes in glucose homeostasis in response to regular exercise in nondiabetic individuals: the HERITAGE family study. Diabetes. 2004 Jun;53(6):1603-8.

305.  Dyck DJ. Leptin sensitivity in skeletal muscle is modulated by diet and exercise. Exerc Sport Sci Rev. 2005 Oct;33(4):189-94. Review.

306.  Kraemer RR et al. Leptin and exercise. Exp Biol Med (Maywood). 2002 Oct;227(9):701-8. Review.

307.  Dengel DR et al. Effects of weight loss by diet alone or combined with aerobic exercise on body composition in older obese men. Metabolism. 1994 Jul;43(7):867-71.

308.  Niklas BJ et al. Exercise blunts declines in lipolysis and fat oxidation after dietary-induced weight loss in obese older women. Am J Physiol. 1997 Jul;273(1 Pt 1):E149-55.